Smith Howard W III 4

4 · Walker & Dunlop, Inc. · Filed Mar 12, 2024

Form 4

Period: 2024-03-08

DirectorEVP and COO

Transactions

Exercise/Conversion
Common Stock
2024-03-08$16.72/sh+20,166$337,176→ 212,674.094 total
Exercise/Conversion
Common Stock
2024-03-08−20,166→ 0 total
Exercise: $16.72From: 2018-02-15Exp: 2025-02-15→ Common Stock (20,166 underlying)
Sale
Common Stock
2024-03-08$92.84/sh−11,667$1,083,155→ 200,007.094 total
Sale
Common Stock
2024-03-08$95.12/sh−4,062$386,374→ 191,508.094 total
Sale
Common Stock
2024-03-08$94.03/sh−4,437$417,207→ 195,570.094 total

Holdings

Footnotes (4)

[F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2023.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.465 to $93.46. The reporting person undertakes to provide the Company, any security holder of the Company, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.76 to $94.53. The reporting person undertakes to provide the Company, any security holder of the Company, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.815 to $95.84. The reporting person undertakes to provide the Company, any security holder of the Company, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file